TLT Explains

Planned Parenthood Closes Major Houston Facility Amid Funding Cuts

By The Liberty Tribune Staff

Published: 10/1/2025 · Updated: 10/1/2025 · 5 min read

Parenthoods Prevention Park, once the largest of its kind in the Western Hemisphere, has.

What's happening

Planned Parenthood Closes Major Houston Facility Amid Funding Cuts — The 80th anniversary of the Nuremberg Trials serves as a critical reminder of the horrors associated with unchecked human experimentation during World War II. This milestone highlights the atrocities that led to the establishment of the 1947 Nuremberg Code, a foundational document in medical ethics that emphasizes informed consent, minimal risk, and the prohibition of exploiting vulnerable human beings. The code prioritizes the safety of all human subjects over any perceived societal benefits. Explainer Amid Review Of Deadly Abortion Drug, FDA Greenlights Copycat However, a significant flaw in U.S. regulations warrants attention: the outdated definitions in 45 Code of Federal Regulations (CFR) Part 46, which governs the protection of human subjects in research funded or conducted by the Department of Health and Human Services (HHS). Critics argue that it is time to align this decades-old law with current scientific understanding of human embryology. While 45 CFR 46 offers baseline protections and additional safeguards for vulnerable populations, it contains misleading definitions regarding fundamental terms related to human development. For instance, the regulation defines a "fetus" as the "product of conception from implantation until delivery" and "pregnancy" as the time from implantation until delivery. Notably, it fails to define the term "embryo," which is critical since the embryonic period is when all major organs and body systems begin to form. Experts in human embryology assert that the first stage of human development begins at fertilization, not implantation. The recent agreement between the Trump administration and pharmaceutical companies Eli Lilly and Novo Nordisk aims to expand affordable coverage for obesity drugs, a move that has been met with both praise and skepticism.

What's at stake

While the initiative is expected to lower the prices of popular drugs like Ozempic and Wegovy, critics argue that the deal may ultimately benefit the pharmaceutical companies more than consumers. Explainer Trump Administration Reassesses Approach to Sanctuary Officials What the Trump obesity drug deal promises The announced that prices for Ozempic and Wegovy would decrease significantly, from $1,000 and $1,350 per month to $350 through a new direct-to-consumer platform called TrumpRx, set to launch next year. Additionally, Medicare prices for these drugs are projected to be $245, which is less than half of the prices proposed by the Biden administration. Supporters of the agreement argue that it could give uninsured or underinsured patients access to treatments that were previously out of reach, potentially improving for millions of Americans struggling with obesity. Why analysts say Big Pharma still comes out ahead However, a Wall Street Journal analysis suggests that these advertised discounts may not reflect the true cost dynamics in the pharmaceutical market. The effective prices that pharmaceutical companies receive after accounting for rebates and discounts are reportedly only 20% to 35% lower than current Medicare payments for Mounjaro, a drug used for diabetes. The direct-to-consumer model is expected to benefit those without insurance coverage for GLP-1 drugs, who currently face inflated prices. Yet, the pharmaceutical companies may only experience a modest reduction in net revenue. Analysts note that the companies are shifting their profit strategy from high margins on fewer customers to lower margins on a larger customer base, which could ultimately enhance their market position.

A panel of three judges has issued an injunction blocking Texas from implementing its newly drawn congressional map, a decision that could significantly affect the state's representation in the upcoming midterm elections. Brown and Judge Davi Guaderrama, found that the map appears to be a race-based gerrymander, which is illegal under federal law. Explainer As A Former DC Cop, The Federal Takeover Was The Right Move The judges ruled 2-1 that the new map, which was expected to add five Republican-leaning seats, likely violates the Act. Texas Republicans argued that the map was drawn based on political preferences, not race. However, the court found this claim unconvincing, stating it is "extremely unlikely" that the map's racial outcomes were coincidental. In a recent opinion piece in The Hill, Jacob Lane criticized the Sanctuary Cities for the Unborn ordinance adopted by Danville, Illinois, in May 2023. "The public perception of this case is that it’s about politics," the majority opinion stated. "But it was much more than just politics. Substantial evidence shows that Texas racially gerrymandered the 2025 map." The court's decision follows a nine-day hearing in El Paso, where the legality of the map was debated. What to watch next is whether new filings, agency actions, votes, or court decisions change the timeline—and how officials respond in the weeks ahead.

Why it matters

The coverage highlights: Supreme Court Allows Texas to Implement New Congressional Map. The coverage highlights: New Law Lets Texans Sue Abortion Drug Traffickers. The coverage highlights: 80 Years After Nuremberg Trials, Doctors Still Commit Atrocities. The coverage highlights: Why Trump's Obesity Drug 'Deal' Will Help Big Pharma Most Of All. The coverage highlights: Judge Critiques Ruling Against Texas Congressional Map. The coverage highlights: Texas Court Blocks New Congressional Map, Impacting Midterm Elections.

Key facts & context

2025-12-05: Supreme Court Allows Texas to Implement New Congressional Map. 2025-12-04: New Law Lets Texans Sue Abortion Drug Traffickers. 2025-11-28: 80 Years After Nuremberg Trials, Doctors Still Commit Atrocities. 2025-11-25: Why Trump's Obesity Drug 'Deal' Will Help Big Pharma Most Of All. 2025-11-20: Judge Critiques Ruling Against Texas Congressional Map. 2025-11-19: Texas Court Blocks New Congressional Map, Impacting Midterm Elections. 2025-11-04: Confirming Thomas Bell Could Bring Justice To The Aborted Babies. 2025-10-03: Pro-Life Sanctuary Cities Are Saving Lives. 2025-10-01: Planned Parenthood Closes Major Houston Facility Amid Funding Cuts. 2025-09-12: Appeals Court Unblocks Plans To Defund Planned Parenthood.

Timeline & key developments

Primary sources

1 — congress.gov